Profile for tralturnperlighkingve
|
Signature2 Feb 2018 AstraZeneca positioned for Product Sales growth from FY 2018. Financial Summary Financial Highlights. • Total Revenue declined by 2% in the year, in line with guidance. Losec/Prilosec. 271. 1. (2). (1). 69. 1. 17. 14. propeciat.com propecia reviews
|
